R-Biopharm is a leading developer of test solutions for clinical diagnostics. In both sectors, the R-Biopharm test kits offer high precision and accuracy, key requirements where patient and consumer health is at risk.
R-Biopharm AG was founded in 1988 as a subsidiary of Röhm GmbH in Darmstadt, Germany. In 1991 it was taken over by the present managing director, Dr. Ralf M. Dreher. Since 1996 R-Biopharm’s quality management systems have been certified to the international standards ISO 9001 and in 2003 the company gained ISO 13485 quality management certification. From January 2000 R-Biopharm acquired sole worldwide distribution rights to Enzymatic BioAnalysis, a product developed by Roche (formerly BOEHRINGER Mannheim). In 2002 R-Biopharm took over Rhône Diagnostics Technologies in Scotland, another supplier of mycotoxin test kits, resulting in successful expansion of its position in the food and feed analysis sector. Today the German parent company R-Biopharm is represented by subsidiaries in the UK, USA, Italy, France, Latin America, Brazil, Spain, Australia and China as well as by a worldwide extensive network of more than 80 distributors. In addition, Switzerland, Austria and the Netherlands are represented by local Country Managers.
In clinical diagnostics R-Biopharm possesses many years of sound experience, particularly in the field of infectious stool diagnostics as well as in the field of serological infection diagnostics and allergy diagnostics. 2006 the clinical product portfolio was extended by innovative test systems in the product lines tumor diagnostics and gastroenterology. R-Biopharm has been a successful player world-wide and is constantly developing new and groundbreaking test systems in the different areas. In this process automation is a main focus from the beginning. All distributed tests are validated and CE-marked.
In both fields, the products have been designed and developed primarily for immunoassay platforms. Nonetheless, there is also a great emphasis on other test formats such as PCR, Lateral Flow, Immunoblots, Immunofluorescence Assays, Immunoaffinity columns or Card Tests. RIDASCREEN®, RIDA®, PREP®,, EASI EXTRACT, and PentoCheck® were world-wide recognized trademarks of R-Biopharm.
R-Biopharm has earned high accolades for its business performance. In 2004 the company achieved a double success, being nominated as a finalist for ‘Entrepreneur of the Year 2004, 2005 and 2006’ as well as being placed in 2004 and 2005 in the ‘Technology Fast 50’, a ranking of Germany’s 50 fastest-growing technology companies.
R-Biopharm’s distinctive policy of partnership and teamwork is an approach valued by its customers and research partners alike. The company’s key objective is to be a dependable point of contact for customers, providing competent advice on every sector it serves.
At R-Biopharm the future looks set to offer further exciting prospects in the fields of clinical diagnostics and food and feed analysis. The foremost challenge is to advance the development of new and versatile fast tests. These will shorten the time it takes to obtain results from a wide range of analytical procedures.